RJ Reynolds Ordered to Pay Altria $95 Million in Patent Dispute

Sep.08.2022
RJ Reynolds Ordered to Pay Altria $95 Million in Patent Dispute
RJR ordered to pay Altria over $95 million for patent infringement on Vuse e-cigarette.

In this illustration, a woman is holding a cigarette in front of the Altria logo. Source: Reuters/Dado Ruvic.


On Wednesday, a jury in North Carolina ruled that RJ Reynolds Vapor Co must pay over $95 million to tobacco giant Altria Group after finding that RJR's best-selling Vuse series of e-cigarettes infringed on three of Altria's patents.


Altria, headquartered in Richmond, Virginia, has accused its competitor RJR of infringing on patents related to e-cigarette devices used for storing and heating liquid nicotine pods. Altria is seeking over 5% in royalties on sales of RJR's Vuse Alto device.


Altria announced in a press release that a Greensboro, North Carolina jury accepted its proposed royalty rates when calculating $95.2 million in past damages awarded, and that RJR may be subject to additional ongoing damages following the expiration of its patents in 2035 after post-trial proceedings.


A copy of the verdict cannot be obtained immediately.


A spokesperson for RJR, based in Winston-Salem, North Carolina, expressed disappointment with the ruling and stated that the company will vigorously defend outstanding issues in court and appeal if necessary.


Murphy Gagné, Executive Vice President and General Counsel of Altria, stated that the company is "pleased that the jury recognized the importance of Altria's innovation and the value of its patents.


On Wednesday, a verdict was reached in a case where Philip Morris International won a $10 million judgement in June in Virginia. The company accused RJR of infringing on two e-cigarette patents with their Vuse Solo and Alto devices.


RJR has filed a lawsuit against Philip Morris and Altria in Virginia, alleging that Philip Morris' IQOS heated tobacco device infringes on its e-cigarette patents. Last November, RJR won an order to block the importation of IQOS from the International Trade Commission.


Statement:


This article is compiled from third-party information and is intended for industry-related communication and education purposes only.


This article does not represent the viewpoint of 2FIRSTS and 2FIRSTS is not able to confirm the authenticity or accuracy of the article's content. The translation of this article is intended only for industry-related communication and research.


Due to limitations in the compilation ability, the compiled article may not fully convey the original expression. Please refer to the original text for accuracy.


2FIRSTS is completely aligned with the Chinese government in regards to any domestic, Hong Kong, Macao, Taiwan, or foreign issues and positions.


The copyright of compiled information belongs to the original media and author, and if there is any infringement, please contact us to request removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
2Firsts Interview with IBVTA: UK Vape Tax May Weaken Harm Reduction Efforts
As the UK prepares to introduce its first-ever vape tax in 2026, questions are growing about how the measure will reshape the country’s harm reduction landscape. IBVTA tells 2Firsts that while it was not in favour of the new duty, it accepts that it is being implemented and is working with regulators to ensure a smooth rollout — warning, however, that higher costs could slow smokers’ transition to safer alternatives.
Oct.07
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
Interview with Vabeen CEO Shuai: Full-Portfolio Push, Compliance-First Strategy to Build Global Competitiveness
At InterTabac 2025, Vabeen CEO Shuai told 2Firsts that Vabeen has launched two flagship products—the multi-flavor pod-mod iPlex and the open-system Billow Pro—while showcasing a complete lineup spanning disposables, pod systems, and open systems. In his view, Vabeen treats “compliance-first” as a long-term strategy and sees strict regulation as an opportunity for industry upgrading. Over the next two to three years, Vabeen will continue to focus on three pillars—compliance, user experience, and
Sep.19
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
DARE Warns Malaysia: Vaping Bans Will Expand Illicit Market; Strengthen Enforcement Within Existing Framework
Malaysia’s policy think tank Datametrics Research and Information Sdn Bhd (DARE) cautions that state- or nationwide bans on e-cigarettes would fuel the illicit market, weaken investor confidence, reduce tax revenues, and cost jobs. DARE argues that authorities should prioritize consistent enforcement under existing laws rather than impose new prohibitions.
Sep.28 by 2FIRSTS.ai
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Tobacco harm reduction advocates criticize COP11 for limiting public participation and call for inclusion of harm reduction products in discussions
Tobacco harm reduction advocates criticize COP11 for limiting public participation and call for inclusion of harm reduction products in discussions
The Conference of the Parties to the World Health Organization's Framework Convention on Tobacco Control (COP11) will convene in Geneva in November to discuss global tobacco control policies. Tobacco harm reduction advocates worry that the meeting may only avoid further policy damage without achieving substantive progress. They point out that COP11 limits public participation and call for strengthened discussion on safe nicotine products.
Sep.30 by 2FIRSTS.ai
Vietnam to Ban Investment and Trade in E-cigarettes and Heated Tobacco, with Exceptions for Export and Research
Vietnam to Ban Investment and Trade in E-cigarettes and Heated Tobacco, with Exceptions for Export and Research
Vietnam’s finance vice minister proposes banning investment and business in e-cigarettes and heated tobacco under a 2024 resolution, with possible exceptions for export-only products and research/medical/defense uses.
Oct.17 by 2FIRSTS.ai